Starpharma enters agrochemical tie-up
16 September, 2013 by Dylan Bushell-EmblingStarpharma (ASX:SPL) revealed that US crop protection company Gowan is considering using its Priostar dendrimer technology in some of its products.
Early screening for dementia leads to overdiagnosis
13 September, 2013The drive for the early diagnosis of dementia may be resulting in overdiagnosis and inappropriate treatment.
Bioinsecticides from spider venom
12 September, 2013 by Susan WilliamsonA newly discovered protein in the venom of Australian tarantulas shows promise as a bioinsecticide for cotton crop pests.
New whooping cough vaccine to be developed
12 September, 2013Researchers at Curtin University, in collaboration with The University of Western Australia (UWA), will soon be developing a new whooping cough vaccine.
DNA barcodes distinguish rainforest plants
11 September, 2013DNA barcoding is facilitating the identification of rainforest plant species in Queensland.
Coridon's herpes vaccine trial progressing well
05 September, 2013 by Dylan Bushell-EmblingCoridon, Allied Healthcare's (ASX:AHZ) 50.1%-owned subsidiary, said no safety issues were raised during dosing of the first two cohorts in a phase I study of its herpes vaccine and treatment.
Seagrass provides blue carbon reserve
05 September, 2013As well as being a favourite feeding ground for dugongs and sea turtles, seagrass meadows may be a major carbon sink for the planet.
2013 Eureka Prize winners
05 September, 2013From diamonds that light up the inside of cells to broody male weedy sea dragons, this year's Australian Museum Eureka Prizes recognise some of the great work and great people in Australian science.
Clinuvel posts follow-up data from vitiligo trial
02 September, 2013 by Dylan Bushell-EmblingDuring a recent trial, Clinuvel's Scenesse (ASX:CUV) was able to improve repigmentation in patients undergoing NB-UVB therapy for vitiligo, and to help sustain the effect.
Measuring brain volume loss
30 August, 2013 by Susan WilliamsonThe Sydney Neuroimaging Analysis Centre, located with the Brain and Mind Research Institute in Sydney, is now home to some sophisticated neuroimaging technology previously unavailable in Australia.
Recognising women in science
28 August, 2013Three early-career scientists have been awarded $25,000 one-year fellowships.
BioDiem wins third US patent for BDM-I
26 August, 2013 by Dylan Bushell-EmblingBioDiem (ASX:BDM) will be granted a US divisional patent covering the use of BDM-I in skin and wound infections caused by different fungi and bacteria.
ReCell vitiligo trial hits recruitment goal
22 August, 2013 by Dylan Bushell-EmblingA clinical trial involving using Avita Medical’s (ASX:AVH) ReCell Spray-on Skin to treat skin pigment disorders has hit its 10-patient recruitment goal.
Industry invests in university Chair
22 August, 2013A new research Chair at the ANU will be funded by Sirtex Medical.
Alchemia earns record fondaparinux profit in Q4
20 August, 2013 by Dylan Bushell-EmblingAlchemia (ASX:ACL) said sales of its generic fondaparinux anticoagulant recovered in the June quarter to reach record levels.
